Astec Lifesciences Ltd.
•₹ 601.850.01%
2026-08-21
PROS
- Promoters have been increasing their shareholding - up 5.2pp over 2 years
- Working capital cycle has improved - days down from -23 to -46
CONS
- Company is loss-making at the operating / net level
- Operating cash flow has been negative in recent years
- Company has a low return on equity of -27.5% over last 3 years
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of -7.6%
- Interest coverage is weak at -1.3x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | UPL | 568.70 | 23.77 | 48007.91 | 1.05 | -73.00 | 58.52 | 10181.00 | 10.47 | 12.00 | 13.43 |
| 2. | PIIND | 2496.00 | 32.51 | 37868.84 | 0.60 | 244.20 | -38.95 | 1702.30 | -10.43 | 16.00 | 21.69 |
| 3. | SUMICHEM | 553.65 | 47.69 | 27635.20 | 0.23 | 214.51 | 20.45 | 1063.35 | 0.62 | 23.39 | 21.94 |
| 4. | BAYERCROP | 4068.40 | 329.99 | 18284.24 | 3.69 | 321.60 | 15.39 | 1835.00 | -4.16 | 30.08 | 20.03 |
| 5. | SHARDACROP | 771.80 | 11.12 | 6963.22 | 1.94 | 88.02 | -38.36 | 1073.77 | 9.03 | 31.10 | 17.32 |
| 6. | DHANUKA | 995.20 | 14.94 | 4436.43 | 0.20 | 75.50 | 27.94 | 442.02 | 20.01 | 24.44 | 24.83 |
| 7. | RALLIS | 211.90 | 25.10 | 4120.80 | 1.42 | -14.15 | -274.26 | 507.54 | 7.70 | 13.23 | -0.56 |
| 8. | NACLIND | 174.00 | 329.49 | 4075.83 | 0.00 | 20.84 | 59.82 | 383.33 | -14.50 | 6.20 | 10.80 |
| 9. | BHAGCHEM | 290.25 | 136.75 | 3763.65 | 0.05 | 133.29 | 3249.84 | 1950.19 | 1475.55 | 4.55 | 15.65 |
| 10. | GSPCROP | 595.35 | 28.29 | 2769.49 | 0.17 | 263.94 | 1111.46 | 3859.95 | 1153.27 | 20.81 | 11.02 |
| 11. | BHARATRAS | 1279.90 | 14.85 | 2127.33 | 0.04 | 372.30 | 838.73 | 3381.60 | 796.03 | 16.63 | 15.19 |
| 12. | ASTEC | 604.15 | 0.00 | 1346.22 | 0.00 | -18.71 | 43.36 | 83.56 | -8.25 | -5.71 | -0.80 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 143 | 111 | 51 | 154 | 69 | 99 | 94 | 120 | 91 | 74 | 125 | 159 | 84 | |
| 140 | 114 | 69 | 141 | 116 | 118 | 100 | 114 | 102 | 80 | 121 | 149 | 103 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 1 |
| Interest | 6 | 6 | 6 | 7 | 7 | 9 | 10 | 10 | 11 | 8 | 7 | 8 | 8 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 11 | 11 | 12 | 11 | 10 | 11 | 12 | 11 |
| -11 | -18 | -32 | -1 | -62 | -39 | -25 | -16 | -33 | -24 | -16 | -8 | -19 | |
| Tax % | 25.61% | 23.75% | 24.49% | -4.35% | 35.56% | -0.03% | -60.52% | -2.68% | -0.03% | -0.04% | -0.06% | 1.90% | 0.17% |
| Net Profit | 0 | 0 | 0 | 0 | -40 | -39 | -40 | -16 | -33 | -24 | -16 | -8 | -19 |
| -4 | -7 | -12 | -0 | -20 | -20 | -21 | -8 | -17 | -11 | -7 | -3 | -1 | |
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 143
- 140
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 6
- Depreciation
- 9
- -11
- Tax %
- 25.61%
- Net Profit
- 0
- -4
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 111
- 114
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 6
- Depreciation
- 9
- -18
- Tax %
- 23.75%
- Net Profit
- 0
- -7
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 51
- 69
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 6
- Depreciation
- 9
- -32
- Tax %
- 24.49%
- Net Profit
- 0
- -12
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 154
- 141
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 7
- Depreciation
- 9
- -1
- Tax %
- -4.35%
- Net Profit
- 0
- -0
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 69
- 116
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 7
- Depreciation
- 9
- -62
- Tax %
- 35.56%
- Net Profit
- -40
- -20
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 99
- 118
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 9
- Depreciation
- 11
- -39
- Tax %
- -0.03%
- Net Profit
- -39
- -20
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 94
- 100
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 10
- Depreciation
- 11
- -25
- Tax %
- -60.52%
- Net Profit
- -40
- -21
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 120
- 114
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 10
- Depreciation
- 12
- -16
- Tax %
- -2.68%
- Net Profit
- -16
- -8
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 91
- 102
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 11
- Depreciation
- 11
- -33
- Tax %
- -0.03%
- Net Profit
- -33
- -17
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 74
- 80
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 8
- Depreciation
- 10
- -24
- Tax %
- -0.04%
- Net Profit
- -24
- -11
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 125
- 121
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 7
- Depreciation
- 11
- -16
- Tax %
- -0.06%
- Net Profit
- -16
- -7
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 159
- 149
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 8
- Depreciation
- 12
- -8
- Tax %
- 1.90%
- Net Profit
- -8
- -3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 84
- 103
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 8
- Depreciation
- 11
- -19
- Tax %
- 0.17%
- Net Profit
- -19
- -1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 299 | 368 | 431 | 523 | 555 | 677 | 628 | 458 | 381 | 448 | 441 | |
| 236 | 299 | 354 | 437 | 443 | 522 | 552 | 464 | 448 | 453 | 454 | |
| Operating Profit | 65 | 77 | 88 | 97 | 119 | 165 | 89 | -0 | -61 | 1 | — |
| OPM % | 22 | 21 | 20 | 19 | 22 | 24 | 14 | -0 | -16 | 0 | — |
| Other Income | 3 | 8 | 11 | 12 | 8 | 10 | 13 | 6 | 6 | 5 | 5 |
| Interest | 12 | 11 | 12 | 13 | 5 | 9 | 21 | 25 | 37 | 35 | 31 |
| Depreciation | 14 | 15 | 19 | 23 | 26 | 34 | 34 | 36 | 44 | 45 | 44 |
| 29 | 56 | 56 | 61 | 89 | 121 | 35 | -62 | -141 | -81 | -67 | |
| Tax % | 33 | 37 | 36 | 23 | 27 | 26 | 27 | 24 | 4 | 0 | 0 |
| Net Profit | 19 | 35 | 36 | 48 | 65 | 90 | 26 | -47 | -135 | -81 | -67 |
| EPS | 10 | 18 | 18 | 24 | 33 | 46 | 13 | -24 | -69 | -36 | — |
| Dividend Payout % | 15 | 8 | 8 | 6 | 5 | 3 | 12 | 0 | 0 | 0 | — |
| Minority Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 18 | 18 | 24 | 33 | 46 | 13 | -24 | -68 | -36 | — |
| Minority Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 18 | 18 | 24 | 33 | 46 | 13 | -24 | -68 | -36 | — |
Mar 2017
- 299
- 236
- Operating Profit
- 65
- OPM %
- 22
- Other Income
- 3
- Interest
- 12
- Depreciation
- 14
- 29
- Tax %
- 33
- Net Profit
- 19
- EPS
- 10
- Dividend Payout %
- 15
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2018
- 368
- 299
- Operating Profit
- 77
- OPM %
- 21
- Other Income
- 8
- Interest
- 11
- Depreciation
- 15
- 56
- Tax %
- 37
- Net Profit
- 35
- EPS
- 18
- Dividend Payout %
- 8
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 18
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 18
Mar 2019
- 431
- 354
- Operating Profit
- 88
- OPM %
- 20
- Other Income
- 11
- Interest
- 12
- Depreciation
- 19
- 56
- Tax %
- 36
- Net Profit
- 36
- EPS
- 18
- Dividend Payout %
- 8
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 18
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 18
Mar 2020
- 523
- 437
- Operating Profit
- 97
- OPM %
- 19
- Other Income
- 12
- Interest
- 13
- Depreciation
- 23
- 61
- Tax %
- 23
- Net Profit
- 48
- EPS
- 24
- Dividend Payout %
- 6
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 24
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 24
Mar 2021
- 555
- 443
- Operating Profit
- 119
- OPM %
- 22
- Other Income
- 8
- Interest
- 5
- Depreciation
- 26
- 89
- Tax %
- 27
- Net Profit
- 65
- EPS
- 33
- Dividend Payout %
- 5
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 33
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 33
Mar 2022
- 677
- 522
- Operating Profit
- 165
- OPM %
- 24
- Other Income
- 10
- Interest
- 9
- Depreciation
- 34
- 121
- Tax %
- 26
- Net Profit
- 90
- EPS
- 46
- Dividend Payout %
- 3
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 46
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 46
Mar 2023
- 628
- 552
- Operating Profit
- 89
- OPM %
- 14
- Other Income
- 13
- Interest
- 21
- Depreciation
- 34
- 35
- Tax %
- 27
- Net Profit
- 26
- EPS
- 13
- Dividend Payout %
- 12
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2024
- 458
- 464
- Operating Profit
- -0
- OPM %
- -0
- Other Income
- 6
- Interest
- 25
- Depreciation
- 36
- -62
- Tax %
- 24
- Net Profit
- -47
- EPS
- -24
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -24
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -24
Mar 2025
- 381
- 448
- Operating Profit
- -61
- OPM %
- -16
- Other Income
- 6
- Interest
- 37
- Depreciation
- 44
- -141
- Tax %
- 4
- Net Profit
- -135
- EPS
- -69
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -68
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -68
Mar 2026
- 448
- 453
- Operating Profit
- 1
- OPM %
- 0
- Other Income
- 5
- Interest
- 35
- Depreciation
- 45
- -81
- Tax %
- 0
- Net Profit
- -81
- EPS
- -36
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -36
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -36
TTM
- 441
- 454
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 31
- Depreciation
- 44
- -67
- Tax %
- 0
- Net Profit
- -67
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 6%
- 5 Years:
- -4%
- 3 Years:
- -11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 4%
- 5 Years:
- -14%
- 3 Years:
- -24%
- 1 Year:
- -27%
RETURN ON EQUITY
- 10 Years:
- 5%
- 5 Years:
- -10%
- 3 Years:
- -27%
- Last Year:
- -26%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 |
| 118 | 149 | 182 | 226 | 289 | 377 | 399 | 349 | 215 | 368 | |
| 126 | 124 | 176 | 99 | 147 | 239 | 285 | 283 | 264 | 310 | |
| Trade Payables | 57 | 100 | 63 | 202 | 128 | 190 | 177 | 89 | 82 | 88 |
| 13 | 20 | 20 | 25 | 94 | 100 | 98 | 234 | 306 | 154 | |
| Total Liabilities | 334 | 413 | 461 | 572 | 678 | 925 | 979 | 975 | 887 | 942 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 103 | 115 | 167 | 194 | 213 | 340 | 318 | 386 | 499 | 459 | |
| Capital Work in Progress | 8 | 42 | 19 | 22 | 112 | 14 | 112 | 148 | 0 | 0 |
| 66 | 78 | 93 | 121 | 106 | 187 | 295 | 196 | 160 | 138 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 169 | 147 | 248 | |
| Cash & Bank | 4 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 12 |
| 153 | 176 | 181 | 233 | 246 | 383 | 252 | 73 | 78 | 85 | |
| Total Assets | 334 | 413 | 461 | 572 | 678 | 925 | 979 | 975 | 887 | 942 |
| Total Debt | 127 | 125 | 176 | 99 | 187 | 279 | 341 | 494 | 555 | 449 |
| Net Working Capital | 5 | -7 | -0 | 13 | 8 | 25 | -27 | 1 | -25 | -57 |
| Contingent Liabilities | 182 | 177 | 185 | 230 | 212 | 244 | 203 | 212 | 157 | 184 |
| Book Value per Share | 70.36 | 86.42 | 103.16 | 125.66 | 157.63 | 202.17 | 213.72 | 188.13 | 119.64 | 175.24 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 127 | 125 | 176 | 99 | 187 | 279 | 341 | 494 | 555 | 449 |
| Net Working Capital | 5 | -7 | -0 | 13 | 8 | 25 | -27 | 1 | -25 | -57 |
| Contingent Liabilities | 182 | 177 | 185 | 230 | 212 | 244 | 203 | 212 | 157 | 184 |
| Book Value per Share | 70.36 | 86.42 | 103.16 | 125.66 | 157.63 | 202.17 | 213.72 | 188.13 | 119.64 | 175.24 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2017
- Equity Capital
- 20
- 118
- 126
- Trade Payables
- 57
- 13
- Total Liabilities
- 334
- 103
- Capital Work in Progress
- 8
- 66
- 0
- Cash & Bank
- 4
- 153
- Total Assets
- 334
- Total Debt
- 127
- Net Working Capital
- 5
- Contingent Liabilities
- 182
- Book Value per Share
- 70.36
- Face Value
- 10.00
- Total Debt
- 127
- Net Working Capital
- 5
- Contingent Liabilities
- 182
- Book Value per Share
- 70.36
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 20
- 149
- 124
- Trade Payables
- 100
- 20
- Total Liabilities
- 413
- 115
- Capital Work in Progress
- 42
- 78
- 0
- Cash & Bank
- 1
- 176
- Total Assets
- 413
- Total Debt
- 125
- Net Working Capital
- -7
- Contingent Liabilities
- 177
- Book Value per Share
- 86.42
- Face Value
- 10.00
- Total Debt
- 125
- Net Working Capital
- -7
- Contingent Liabilities
- 177
- Book Value per Share
- 86.42
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 20
- 182
- 176
- Trade Payables
- 63
- 20
- Total Liabilities
- 461
- 167
- Capital Work in Progress
- 19
- 93
- 0
- Cash & Bank
- 1
- 181
- Total Assets
- 461
- Total Debt
- 176
- Net Working Capital
- -0
- Contingent Liabilities
- 185
- Book Value per Share
- 103.16
- Face Value
- 10.00
- Total Debt
- 176
- Net Working Capital
- -0
- Contingent Liabilities
- 185
- Book Value per Share
- 103.16
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 20
- 226
- 99
- Trade Payables
- 202
- 25
- Total Liabilities
- 572
- 194
- Capital Work in Progress
- 22
- 121
- 0
- Cash & Bank
- 1
- 233
- Total Assets
- 572
- Total Debt
- 99
- Net Working Capital
- 13
- Contingent Liabilities
- 230
- Book Value per Share
- 125.66
- Face Value
- 10.00
- Total Debt
- 99
- Net Working Capital
- 13
- Contingent Liabilities
- 230
- Book Value per Share
- 125.66
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 20
- 289
- 147
- Trade Payables
- 128
- 94
- Total Liabilities
- 678
- 213
- Capital Work in Progress
- 112
- 106
- 0
- Cash & Bank
- 2
- 246
- Total Assets
- 678
- Total Debt
- 187
- Net Working Capital
- 8
- Contingent Liabilities
- 212
- Book Value per Share
- 157.63
- Face Value
- 10.00
- Total Debt
- 187
- Net Working Capital
- 8
- Contingent Liabilities
- 212
- Book Value per Share
- 157.63
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 20
- 377
- 239
- Trade Payables
- 190
- 100
- Total Liabilities
- 925
- 340
- Capital Work in Progress
- 14
- 187
- 0
- Cash & Bank
- 2
- 383
- Total Assets
- 925
- Total Debt
- 279
- Net Working Capital
- 25
- Contingent Liabilities
- 244
- Book Value per Share
- 202.17
- Face Value
- 10.00
- Total Debt
- 279
- Net Working Capital
- 25
- Contingent Liabilities
- 244
- Book Value per Share
- 202.17
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 20
- 399
- 285
- Trade Payables
- 177
- 98
- Total Liabilities
- 979
- 318
- Capital Work in Progress
- 112
- 295
- 0
- Cash & Bank
- 2
- 252
- Total Assets
- 979
- Total Debt
- 341
- Net Working Capital
- -27
- Contingent Liabilities
- 203
- Book Value per Share
- 213.72
- Face Value
- 10.00
- Total Debt
- 341
- Net Working Capital
- -27
- Contingent Liabilities
- 203
- Book Value per Share
- 213.72
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 20
- 349
- 283
- Trade Payables
- 89
- 234
- Total Liabilities
- 975
- 386
- Capital Work in Progress
- 148
- 196
- 169
- Cash & Bank
- 2
- 73
- Total Assets
- 975
- Total Debt
- 494
- Net Working Capital
- 1
- Contingent Liabilities
- 212
- Book Value per Share
- 188.13
- Face Value
- 10.00
- Total Debt
- 494
- Net Working Capital
- 1
- Contingent Liabilities
- 212
- Book Value per Share
- 188.13
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 20
- 215
- 264
- Trade Payables
- 82
- 306
- Total Liabilities
- 887
- 499
- Capital Work in Progress
- 0
- 160
- 147
- Cash & Bank
- 3
- 78
- Total Assets
- 887
- Total Debt
- 555
- Net Working Capital
- -25
- Contingent Liabilities
- 157
- Book Value per Share
- 119.64
- Face Value
- 10.00
- Total Debt
- 555
- Net Working Capital
- -25
- Contingent Liabilities
- 157
- Book Value per Share
- 119.64
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 22
- 368
- 310
- Trade Payables
- 88
- 154
- Total Liabilities
- 942
- 459
- Capital Work in Progress
- 0
- 138
- 248
- Cash & Bank
- 12
- 85
- Total Assets
- 942
- Total Debt
- 449
- Net Working Capital
- -57
- Contingent Liabilities
- 184
- Book Value per Share
- 175.24
- Face Value
- 10.00
- Total Debt
- 449
- Net Working Capital
- -57
- Contingent Liabilities
- 184
- Book Value per Share
- 175.24
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 65 | 15 | 168 | -8 | 24 | 75 | 10 | -8 | -81 | |
| Cash from Investing | -18 | -49 | -52 | -74 | -73 | -104 | -113 | -135 | -15 | -4 |
| Cash from Financing | -1 | -18 | 37 | -95 | 81 | 80 | 38 | 125 | 24 | 94 |
| 1 | -3 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 9 | |
| Free Cash Flow | 10 | 5 | -33 | 115 | -142 | -40 | -35 | -130 | -17 | -86 |
| OCF / Net Profit | 1.00 | 1.85 | 0.43 | 3.54 | -0.13 | 0.26 | 2.92 | -0.22 | 0.06 | 1.00 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -45 | -95 | -135 | -232 | -364 | -308 |
| OCF / Net Profit | 1.00 | 1.85 | 0.43 | 3.54 | -0.13 | 0.26 | 2.92 | -0.22 | 0.06 | 1.00 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -45 | -95 | -135 | -232 | -364 | -308 |
Mar 2017
- 19
- Cash from Investing
- -18
- Cash from Financing
- -1
- 1
- Free Cash Flow
- 10
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
Mar 2018
- 65
- Cash from Investing
- -49
- Cash from Financing
- -18
- -3
- Free Cash Flow
- 5
- OCF / Net Profit
- 1.85
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.85
- Cumulative 5-Year FCF
- 0
Mar 2019
- 15
- Cash from Investing
- -52
- Cash from Financing
- 37
- -0
- Free Cash Flow
- -33
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
Mar 2020
- 168
- Cash from Investing
- -74
- Cash from Financing
- -95
- 0
- Free Cash Flow
- 115
- OCF / Net Profit
- 3.54
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.54
- Cumulative 5-Year FCF
- 0
Mar 2021
- -8
- Cash from Investing
- -73
- Cash from Financing
- 81
- 0
- Free Cash Flow
- -142
- OCF / Net Profit
- -0.13
- Cumulative 5-Year FCF
- -45
- OCF / Net Profit
- -0.13
- Cumulative 5-Year FCF
- -45
Mar 2022
- 24
- Cash from Investing
- -104
- Cash from Financing
- 80
- 0
- Free Cash Flow
- -40
- OCF / Net Profit
- 0.26
- Cumulative 5-Year FCF
- -95
- OCF / Net Profit
- 0.26
- Cumulative 5-Year FCF
- -95
Mar 2023
- 75
- Cash from Investing
- -113
- Cash from Financing
- 38
- -0
- Free Cash Flow
- -35
- OCF / Net Profit
- 2.92
- Cumulative 5-Year FCF
- -135
- OCF / Net Profit
- 2.92
- Cumulative 5-Year FCF
- -135
Mar 2024
- 10
- Cash from Investing
- -135
- Cash from Financing
- 125
- -0
- Free Cash Flow
- -130
- OCF / Net Profit
- -0.22
- Cumulative 5-Year FCF
- -232
- OCF / Net Profit
- -0.22
- Cumulative 5-Year FCF
- -232
Mar 2025
- -8
- Cash from Investing
- -15
- Cash from Financing
- 24
- 0
- Free Cash Flow
- -17
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- -364
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- -364
Mar 2026
- -81
- Cash from Investing
- -4
- Cash from Financing
- 94
- 9
- Free Cash Flow
- -86
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- -308
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- -308
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 9.80 | 17.87 | 18.28 | 24.28 | 33.21 | 45.85 | 13.04 | -23.93 | -68.71 | -36.31 |
| Book Value (₹) | 70.36 | 86.42 | 103.16 | 125.66 | 157.63 | 202.17 | 213.72 | 188.13 | 119.64 | 175.24 |
| Dividend per Share (₹) | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 16.72 | 25.28 | 27.98 | 35.86 | 45.98 | 62.94 | 30.00 | -5.39 | -46.06 | -16.14 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 20.82% | 20.74% | 20.25% | 18.48% | 21.38% | 24.20% | 14.15% | -1.29% | -17.00% | -1.01% |
| Net Margin % | 6.12% | 9.45% | 8.27% | 9.04% | 11.64% | 13.22% | 4.05% | -10.21% | -34.60% | -18.05% |
| ROE % | 15.07% | 22.90% | 19.31% | 21.24% | 23.46% | 25.50% | 6.28% | -11.90% | -44.64% | -25.88% |
| ROCE % | 16.08% | 23.75% | 20.31% | 20.44% | 22.29% | 22.21% | 7.75% | -4.50% | -12.62% | -5.71% |
| 5.80% | 9.38% | 8.18% | 9.20% | 10.42% | 11.21% | 2.69% | -4.80% | -14.47% | -8.84% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 111 | 115 | 103 | 98 | 114 | 124 | 124 | 129 | 148 | 161 |
| Inventory Days | 80 | 71 | 72 | 74 | 74 | 79 | 139 | 195 | 167 | 121 |
| Payable Days | 127 | 122 | 107 | 143 | 176 | 150 | 167 | 152 | 105 | 104 |
| 64 | 64 | 69 | 29 | 12 | 52 | 96 | 171 | 210 | 179 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.92x | 0.74x | 0.87x | 0.40x | 0.61x | 0.71x | 0.81x | 1.34x | 2.36x | 1.15x |
| Interest Coverage (x) | 3.35x | 6.23x | 5.52x | 5.87x | 19.75x | 14.37x | 2.69x | -1.45x | -2.84x | -1.35x |
| 1.02x | 0.97x | 1.00x | 1.04x | 1.03x | 1.05x | 0.95x | 1.00x | 0.93x | 0.89x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 20.92% | 23.07% | 17.23% | 21.28% | 6.17% | 21.93% | -7.15% | -27.06% | -16.78% | 17.53% |
| Operating Profit Growth % | 68.30% | 17.83% | 13.95% | 10.82% | 23.03% | 37.72% | -45.72% | -100.30% | 0.00% | 100.90% |
| Net Profit Growth % | 278.55% | 82.69% | 2.08% | 32.89% | 36.91% | 38.13% | -71.53% | -283.21% | -187.29% | 39.96% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -283.54% | -187.11% | 47.15% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.65x | 5.64x | 3.08x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -9579.67x | -30.96x | 3007.12x |
Mar 2017
- EPS (₹)
- 9.80
- Book Value (₹)
- 70.36
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 16.72
- Operating Margin %
- 20.82%
- Net Margin %
- 6.12%
- ROE %
- 15.07%
- ROCE %
- 16.08%
- 5.80%
- Debtor Days
- 111
- Inventory Days
- 80
- Payable Days
- 127
- 64
- Debt to Equity (x)
- 0.92x
- Interest Coverage (x)
- 3.35x
- 1.02x
- Revenue Growth %
- 20.92%
- Operating Profit Growth %
- 68.30%
- Net Profit Growth %
- 278.55%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 17.87
- Book Value (₹)
- 86.42
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 25.28
- Operating Margin %
- 20.74%
- Net Margin %
- 9.45%
- ROE %
- 22.90%
- ROCE %
- 23.75%
- 9.38%
- Debtor Days
- 115
- Inventory Days
- 71
- Payable Days
- 122
- 64
- Debt to Equity (x)
- 0.74x
- Interest Coverage (x)
- 6.23x
- 0.97x
- Revenue Growth %
- 23.07%
- Operating Profit Growth %
- 17.83%
- Net Profit Growth %
- 82.69%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 18.28
- Book Value (₹)
- 103.16
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 27.98
- Operating Margin %
- 20.25%
- Net Margin %
- 8.27%
- ROE %
- 19.31%
- ROCE %
- 20.31%
- 8.18%
- Debtor Days
- 103
- Inventory Days
- 72
- Payable Days
- 107
- 69
- Debt to Equity (x)
- 0.87x
- Interest Coverage (x)
- 5.52x
- 1.00x
- Revenue Growth %
- 17.23%
- Operating Profit Growth %
- 13.95%
- Net Profit Growth %
- 2.08%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 24.28
- Book Value (₹)
- 125.66
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 35.86
- Operating Margin %
- 18.48%
- Net Margin %
- 9.04%
- ROE %
- 21.24%
- ROCE %
- 20.44%
- 9.20%
- Debtor Days
- 98
- Inventory Days
- 74
- Payable Days
- 143
- 29
- Debt to Equity (x)
- 0.40x
- Interest Coverage (x)
- 5.87x
- 1.04x
- Revenue Growth %
- 21.28%
- Operating Profit Growth %
- 10.82%
- Net Profit Growth %
- 32.89%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 33.21
- Book Value (₹)
- 157.63
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 45.98
- Operating Margin %
- 21.38%
- Net Margin %
- 11.64%
- ROE %
- 23.46%
- ROCE %
- 22.29%
- 10.42%
- Debtor Days
- 114
- Inventory Days
- 74
- Payable Days
- 176
- 12
- Debt to Equity (x)
- 0.61x
- Interest Coverage (x)
- 19.75x
- 1.03x
- Revenue Growth %
- 6.17%
- Operating Profit Growth %
- 23.03%
- Net Profit Growth %
- 36.91%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 45.85
- Book Value (₹)
- 202.17
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 62.94
- Operating Margin %
- 24.20%
- Net Margin %
- 13.22%
- ROE %
- 25.50%
- ROCE %
- 22.21%
- 11.21%
- Debtor Days
- 124
- Inventory Days
- 79
- Payable Days
- 150
- 52
- Debt to Equity (x)
- 0.71x
- Interest Coverage (x)
- 14.37x
- 1.05x
- Revenue Growth %
- 21.93%
- Operating Profit Growth %
- 37.72%
- Net Profit Growth %
- 38.13%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 13.04
- Book Value (₹)
- 213.72
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 30.00
- Operating Margin %
- 14.15%
- Net Margin %
- 4.05%
- ROE %
- 6.28%
- ROCE %
- 7.75%
- 2.69%
- Debtor Days
- 124
- Inventory Days
- 139
- Payable Days
- 167
- 96
- Debt to Equity (x)
- 0.81x
- Interest Coverage (x)
- 2.69x
- 0.95x
- Revenue Growth %
- -7.15%
- Operating Profit Growth %
- -45.72%
- Net Profit Growth %
- -71.53%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -23.93
- Book Value (₹)
- 188.13
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -5.39
- Operating Margin %
- -1.29%
- Net Margin %
- -10.21%
- ROE %
- -11.90%
- ROCE %
- -4.50%
- -4.80%
- Debtor Days
- 129
- Inventory Days
- 195
- Payable Days
- 152
- 171
- Debt to Equity (x)
- 1.34x
- Interest Coverage (x)
- -1.45x
- 1.00x
- Revenue Growth %
- -27.06%
- Operating Profit Growth %
- -100.30%
- Net Profit Growth %
- -283.21%
- -283.54%
- P/E (x)
- 0.00x
- P/B (x)
- 5.65x
- Dividend Yield %
- 0.00%
- -9579.67x
Mar 2025
- EPS (₹)
- -68.71
- Book Value (₹)
- 119.64
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -46.06
- Operating Margin %
- -17.00%
- Net Margin %
- -34.60%
- ROE %
- -44.64%
- ROCE %
- -12.62%
- -14.47%
- Debtor Days
- 148
- Inventory Days
- 167
- Payable Days
- 105
- 210
- Debt to Equity (x)
- 2.36x
- Interest Coverage (x)
- -2.84x
- 0.93x
- Revenue Growth %
- -16.78%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- -187.29%
- -187.11%
- P/E (x)
- 0.00x
- P/B (x)
- 5.64x
- Dividend Yield %
- 0.00%
- -30.96x
Mar 2026
- EPS (₹)
- -36.31
- Book Value (₹)
- 175.24
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -16.14
- Operating Margin %
- -1.01%
- Net Margin %
- -18.05%
- ROE %
- -25.88%
- ROCE %
- -5.71%
- -8.84%
- Debtor Days
- 161
- Inventory Days
- 121
- Payable Days
- 104
- 179
- Debt to Equity (x)
- 1.15x
- Interest Coverage (x)
- -1.35x
- 0.89x
- Revenue Growth %
- 17.53%
- Operating Profit Growth %
- 100.90%
- Net Profit Growth %
- 39.96%
- 47.15%
- P/E (x)
- 0.00x
- P/B (x)
- 3.08x
- Dividend Yield %
- 0.00%
- 3007.12x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-01 - Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
- Updates
2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding 'Adoption of Annual Report 2025-26 by the Shareholders at the AGM held on 31st July, 2026.'.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nov 2022
May 2022
Nov 2021